> |
The Immune Pharmacology within the Center of Pharmacology offers sophisticated expertise in vitro test systems and in vivo models of chronic inflammation and for the immune therapy of human diseases such as nephritis, rheumatoid arthritis, psoriasis, inflammatory bowel diseases, transplantation, immune endocrinopathies and the immunology of tumor initiation and progression. With this background the group is focused on a translational approach to develop and validate new types of immune modulators such as sphingolipid or vitamin D analogs and chemokine antagonists and finally targeted pharmaceutical delivery techniques for recombinant proteins, therapeutic oligonucleotides and lentiviral shuttle vectors for e.g. shRNAs to treat the sequelae or in the best case cure chronic inflammatory diseases.
|
